Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
home:diseases:celiac [02.19.2019]
sallieq [recent research]
home:diseases:celiac [03.13.2019] (current)
sallieq [recent research]
Line 63: Line 63:
 [[http://​science.sciencemag.org/​content/​356/​6333/​44| study in humans supports a role for infection with reovirus, a seemingly innocuous virus, in triggering the development of CeD]] [[http://​science.sciencemag.org/​content/​356/​6333/​44| study in humans supports a role for infection with reovirus, a seemingly innocuous virus, in triggering the development of CeD]]
 (({{pubmed>​long:​28386004}})) (({{pubmed>​long:​26060107}})) (({{pubmed>​long:​28386004}})) (({{pubmed>​long:​26060107}}))
 +
 +Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely. ​ (({{pubmed>​long:​25023670}}))
 +
 +In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity. ​  ​(({{pubmed>​long:​25947920}}))
  
 {{tag>​diseases }} {{tag>​diseases }}
home/diseases/celiac.txt · Last modified: 03.13.2019 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.